Markedly elevated levels of plasma advanced glycation end products in patients with liver cirrhosis – amelioration by liver transplantation
- 1 January 2002
- journal article
- research article
- Published by Elsevier in Journal of Hepatology
- Vol. 36 (1) , 66-71
- https://doi.org/10.1016/s0168-8278(01)00232-x
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Scavenger Receptor Class B Type I-mediated Reverse Cholesterol Transport Is Inhibited by Advanced Glycation End ProductsJournal of Biological Chemistry, 2001
- Endocytic uptake of advanced glycation end products by mouse liver sinusoidal endothelial cells is mediated by a scavenger receptor distinct from the macrophage scavenger receptor class ABiochemical Journal, 2000
- Formation of plasma advanced glycosylation end products (AGEs) has no influence on plasma viscosityDiabetic Medicine, 1997
- Advanced glycation end products are eliminated by scavenger-receptor-mediated endocytosis in hepatic sinusoidal Kupffer and endothelial cellsBiochemical Journal, 1997
- Molecular identity and cellular distribution of advanced glycation endproduct receptors: relationship of p60 to OST-48 and p90 to 80K-H membrane proteins.Proceedings of the National Academy of Sciences, 1996
- ADVANCED PROTEIN GLYCOSYLATION IN DIABETES AND AGINGAnnual Review of Medicine, 1995
- Advanced Glycosylation: Chemistry, Biology, and Implications for Diabetes and AgingPublished by Elsevier ,1992
- Two novel rat liver membrane proteins that bind advanced glycosylation endproducts: relationship to macrophage receptor for glucose-modified proteins.The Journal of Experimental Medicine, 1991
- Lidocaine Metabolite Formation as a Measure of Liver Function in Patients with CirrhosisTherapeutic Drug Monitoring, 1990
- Transection of the oesophagus for bleeding oesophageal varicesBritish Journal of Surgery, 1973